EP. 1: The Targeted Pulse: Catch Up on AUA, AACR, and More
Check out the latest oncology news from this week, including highlights from the 2025 American Association for Cancer Research and American Urological Association annual meetings.
EP. 2: The Targeted Pulse: New Therapies for Melanoma, Myeloma, and More
The FDA has cleared investigational new drug applications and handed out fast track designations. Plus, data shows promise for novel therapies in hard-to-treat cancers.
EP. 3: The Targeted Pulse: FDA Approvals in Ovarian Cancer, Lung Cancer, and More
The FDA has approved new agents in ovarian cancer and non–small cell lung cancer and paved the way for novel antibody-drug conjugate developments.
